The U.S. healthcare giant Johnson & Johnson buys Switzerland based bio-pharmaceutical firm, Actelion, for $30billion (27.9 billion euros). Johnson & Johnson will acquire all the outstanding shares of Actelion for $280 per share with the tender offer to start by mid-February, 2017.
So, let’s discuss some questions related to this post:
Q1. Name the company, which has been acquired by pharmaceutical firm Johnson & Johnson for $30 billion, recently?
Ans1. Actelion
Source-The Indian Express
Job Alerts